Literature DB >> 9949164

Cooperative activity of alpha4beta1 and alpha4beta7 integrins in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin through recognition of multiple synergizing binding sites within the central cell-binding domain.

Z Yin1, E Giacomello, E Gabriele, L Zardi, S Aota, K M Yamada, B Skerlavaji, R Doliana, A Colombatti, R Perris.   

Abstract

We have quantitated the relative contributions of the constitutively active alpha4beta1 and alpha4beta7 integrins and the domains embodying their cognate binding sites in mediating human B-cell lymphoma adhesion and chemotaxis on fibronectin. By cooperating, the central cell-binding and IIICS carboxy-terminal domains were entirely responsible for the adhesion activity displayed by fibronectin, and their relative contribution to this process was estimated to be 30% versus 70%. Assessment of the leukocyte-substrate binding strength (ie, dynes/cell) indicated a 10-fold higher avidity of the cell-IIICS domain interaction. The two integrins interchangeably recognized both domains, but differed quantitatively in their participation in the adhesive event, as well as in domain preference. The use of 3Fn (according to the nomenclature proposed by Bork and Koonin [Curr Opin Struct Biol 6:366, 1996] for the type III fibronectin modules) module-specific antibodies and recombinant polypeptides showed that alpha4 integrins recognized both the RGD sequence (3Fn10) and an apparently novel synergistic site located within the 3Fn8 module; even in this case, the integrins displayed a distinct binding site preference. Interleukin-1beta (IL-1beta)/IL-2-induced chemotaxis also involved cooperative function of the central cell-binding and IIICS domains, but the mechanisms regulating this phenomenon differed markedly from those controlling cell adhesion. First, the relative contribution of the individual domains was comparable, but neither of the individual domains promoted migration to the extent observed on intact fibronectin. Secondly, alpha4beta1 and alpha4beta7 integrins were both involved in the domain-binding necessary for initiation of migration, but the relative contribution of each receptor in the chemotactic process was less disparate than for initial cell adhesion. Thirdly, the mode by which chemotactic B-lymphoma movement was supported by the central cell-binding domain differed from that sustaining cell adhesion in that it involved independent recognition of either the 3Fn8 or the 3Fn9 module, which acted in synergy with the 3Fn10 module. Our data provide novel evidence concerning the relative importance of the constitutively active alpha4beta1 and alpha4beta7 integrins for the interaction of B-cell lymphoma cells with fibronectin, and they emphasize a multiple and diverse recognition of sites responsible for either anchorage or locomotion of tumor leukocytes on this matrix molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949164

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Adhesion to fibronectin promotes the activation of the p125(FAK)/Zap-70complex in human T cells.

Authors:  A Bearz; G Tell; S Formisano; S Merluzzi; A Colombatti; C Pucillo
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  Synergistic activity of the ninth and tenth FIII domains of human fibronectin depends upon structural stability.

Authors:  Harri Altroff; Laurence Choulier; Helen J Mardon
Journal:  J Biol Chem       Date:  2002-10-09       Impact factor: 5.157

3.  De novo CD5 positive diffuse large B-cell lymphomas with bone marrow involvement in Korean.

Authors:  Sun-Young Kong; Eun Hae Cho; Hee Yeon Woo; Qeuhn Park; Young Hyeh Ko; Sun-Hee Kim
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

4.  Integrin-dependence of lymphocyte entry into the splenic white pulp.

Authors:  Charles G Lo; Theresa T Lu; Jason G Cyster
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.